Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Hung

Showing results (521-530 of 563) with videos related to

Pageof 57
Sort By:
Liver Cancer|July 21, 2025
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor AblationMing Shun Wu, Wei-Yu Kao, Ming-Feng Chiang, et al.
Scientific Reports|September 27, 2016
MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirinYi-Hao Yen, Chao-Min Huang, Kuo-Liang Wei, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 12, 2018
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutionsMing-Lung Yu, Chao-Hung Hung, Yi-Hsiang Huang, et al.
Viruses|January 21, 2023
Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver CirrhosisYung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, et al.
Computer Methods and Programs in Biomedicine|February 20, 2025
Deep-learning-based diagnosis framework for ankle-brachial index defined peripheral arterial disease of lower extremity wound: Comparison with physiciansMing-Feng Tsai, Yu-Chang Chu, Wen-Teng Yao, et al.
The Journal of Infectious Diseases|April 9, 2019
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated SubstitutionsChung-Feng Huang, Chao-Hung Hung, Pin-Nan Cheng, et al.
BMC Medical Informatics and Decision Making|April 11, 2026
Deep-learning-based diagnostic models for transcutaneous oxygen pressure-defined peripheral arterial disease and lower extremity wound healing in patients with diabetic footMing-Feng Tsai, Chen-Shen Shih, Yu-Fan Chen, et al.
Scientific Reports|July 30, 2021
Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody-drug conjugates from synthetic antibody librariesHung-Ju Hsu, Chao-Ping Tung, Chung-Ming Yu, et al.
Hepatology International|February 24, 2026
Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablationChing-Wei Chang, Ming-Shun Wu, Wei-Yu Kao, et al.
Clinical and Molecular Hepatology|August 4, 2025
Taiwan Liver Cancer Association Management Consensus Guidelines for Intermediate Stage Hepatocellular CarcinomaI-Cheng Lee, Hung-Wei Wang, Wei Teng, et al.
Pageof 57

Showing results (521-530 of 563) with videos related to

Sort By:
Pageof 57
Liver Cancer|July 21, 2025
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor AblationMing Shun Wu, Wei-Yu Kao, Ming-Feng Chiang, et al.
Scientific Reports|September 27, 2016
MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirinYi-Hao Yen, Chao-Min Huang, Kuo-Liang Wei, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 12, 2018
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutionsMing-Lung Yu, Chao-Hung Hung, Yi-Hsiang Huang, et al.
Viruses|January 21, 2023
Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver CirrhosisYung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, et al.
Computer Methods and Programs in Biomedicine|February 20, 2025
Deep-learning-based diagnosis framework for ankle-brachial index defined peripheral arterial disease of lower extremity wound: Comparison with physiciansMing-Feng Tsai, Yu-Chang Chu, Wen-Teng Yao, et al.
The Journal of Infectious Diseases|April 9, 2019
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated SubstitutionsChung-Feng Huang, Chao-Hung Hung, Pin-Nan Cheng, et al.
BMC Medical Informatics and Decision Making|April 11, 2026
Deep-learning-based diagnostic models for transcutaneous oxygen pressure-defined peripheral arterial disease and lower extremity wound healing in patients with diabetic footMing-Feng Tsai, Chen-Shen Shih, Yu-Fan Chen, et al.
Scientific Reports|July 30, 2021
Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody-drug conjugates from synthetic antibody librariesHung-Ju Hsu, Chao-Ping Tung, Chung-Ming Yu, et al.
Hepatology International|February 24, 2026
Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablationChing-Wei Chang, Ming-Shun Wu, Wei-Yu Kao, et al.
Clinical and Molecular Hepatology|August 4, 2025
Taiwan Liver Cancer Association Management Consensus Guidelines for Intermediate Stage Hepatocellular CarcinomaI-Cheng Lee, Hung-Wei Wang, Wei Teng, et al.
Pageof 57